Characterization of Biophysical and Metabolic Properties of Cells Labeled with Superparamagnetic Iron Oxide Nanoparticles and Transfection Agent for Cellular MR Imaging
Top Cited Papers
- 1 December 2003
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 229 (3) , 838-846
- https://doi.org/10.1148/radiol.2293021215
Abstract
To evaluate the effect of using the ferumoxides-poly-l-lysine (PLL) complex for magnetic cell labeling on the long-term viability, function, metabolism, and iron utilization of mammalian cells. PLL was incubated with ferumoxides for 60 minutes, incompletely coating the superparamagnetic iron oxide (SPIO) through electrostatic interactions. Cells were coincubated overnight with the ferumoxides-PLL complex, and iron uptake, cell viability, apoptosis indexes, and reactive oxygen species formation were evaluated. The disappearance or the life span of the detectable iron nanoparticles in cells was also evaluated. The iron concentrations in the media also were assessed at different time points. Data were expressed as the mean +/- 1 SD, and one-way analysis of variance and the unpaired Student t test were used to test for significant differences. Intracytoplasmic nanoparticles were stained with Prussian blue when the ferumoxides-PLL complex had magnetically labeled the human mesenchymal stem and HeLa cells. The long-term viability, growth rate, and apoptotic indexes of the labeled cells were unaffected by the endosomal incorporation of SPIO, as compared with these characteristics of the nonlabeled cells. In nondividing human mesenchymal stem cells, endosomal iron nanoparticles could be detected after 7 weeks; however, in rapidly dividing cells, intracellular iron had disappeared by five to eight divisions. A nonsignificant transient increase in reactive oxygen species production was seen in the human mesenchymal stem and HeLa cell lines. Labeled human mesenchymal stem cells did not differentiate to other lineage. A significant increase in iron concentration was observed in both the human mesenchymal stem and HeLa cell media at day 7. Magnetic cellular labeling with the ferumoxides-PLL complex had no short- or long-term toxic effects on tumor or stem cells.Keywords
This publication has 23 references indexed in Scilit:
- Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cellsNature Biotechnology, 2001
- Iron metabolism, free radicals, and oxidative injuryBiomedicine & Pharmacotherapy, 2001
- Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cellsNature Biotechnology, 2000
- High-Efficiency Intracellular Magnetic Labeling with Novel Superparamagnetic-Tat Peptide ConjugatesBioconjugate Chemistry, 1999
- Embryonic Stem Cell Lines Derived from Human BlastocystsScience, 1998
- Iron deprivation‐induced apoptosis in HL‐60 cellsFEBS Letters, 1994
- Antiproliferative effect of desferrioxamine on vascular smooth muscle cells in vitro and in vivo.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Iron oxide nanoparticles for use as an MRI contrast agent: Pharmacokinetics and metabolismMagnetic Resonance Imaging, 1991
- Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years.American Journal of Roentgenology, 1990
- Superparamagnetic iron oxide: pharmacokinetics and toxicityAmerican Journal of Roentgenology, 1989